Kunming Longjin Pharmaceutical Co., Ltd.
SZSE:002750.SZ
9.92 (CNY) • At close October 26, 2023
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | |||||||||||||
| Nettowinst
| -84.261 | -73.528 | -7.46 | 7.754 | -23.937 | 13.828 | 35.16 | 91.001 | 61.763 | 63.573 | 75.056 | 100.2 | 69.66 |
| Afschrijvingen & Amortisatie
| 30.589 | 29.786 | 30.837 | 28.264 | 26.196 | 22.791 | 22.069 | 22.22 | 22.493 | 22.303 | 3.805 | 2.265 | 2.318 |
| Uitgestelde Inkomstenbelasting
| 0 | 4.693 | -0.678 | -0.512 | 1.757 | 1.578 | -8.133 | -1.563 | -0.158 | 0 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verandering in Werkkapitaal
| -7.204 | 6.272 | -42.287 | -39.693 | -24.215 | -8.078 | 4.586 | 21.341 | -13.138 | -15.919 | 27.733 | 11.268 | 7.125 |
| Vorderingen
| 7.758 | 13.288 | -94.556 | -11.295 | 5.428 | 3.038 | -31.428 | -15.248 | -3.283 | -4.449 | -5.72 | 0 | 0 |
| Voorraden
| -1.642 | -8.293 | 20.501 | -20.193 | -14.149 | 2.685 | -6.819 | -4.812 | -2.05 | -4.147 | -1.772 | -3.085 | 0.656 |
| Crediteuren
| -14.957 | -3.416 | 32.446 | -7.693 | -17.251 | -11 | 50.965 | 42.965 | -7.648 | 0 | 0 | 0 | 0 |
| Overig Werkkapitaal
| 1.637 | 4.693 | -0.678 | -0.512 | 1.757 | -10.763 | 11.405 | 26.153 | -11.089 | -11.772 | 29.506 | 14.353 | 6.468 |
| Overige Niet-Contante Posten
| 21.616 | 23.027 | 4.106 | -3.102 | 25.999 | 3.158 | -3.757 | -30.324 | -0.933 | 0.206 | -0.136 | -22.57 | -3.204 |
| Kasstroom uit Operationele Activiteiten
| -39.261 | -14.443 | -14.804 | -6.777 | 4.043 | 31.699 | 58.057 | 104.239 | 70.185 | 70.163 | 106.458 | 91.163 | 75.899 |
| Investeringsactiviteiten: | |||||||||||||
| Investeringen in Materiële Vaste Activa
| -15.665 | -25.22 | -10.351 | -23.61 | -7.074 | -15.532 | -17.539 | -23.555 | -23.934 | -18.473 | -59.572 | -74.137 | -92.789 |
| Netto Overnames
| 14.603 | 17.713 | 11.726 | 23.954 | -25.934 | -13.728 | 17.539 | 0.408 | 0.37 | 0 | 0.111 | 0 | 0 |
| Aankoop van Beleggingen
| -1,254.2 | -1,025.21 | -1,169.8 | -1,166.46 | -2,051.6 | -423.525 | -1,356 | -2,276.499 | -405.1 | -12 | -42 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 1,344.4 | 1,148.373 | 1,138.441 | 1,093.988 | 1,867.808 | 732.77 | 1,391.023 | 2,071.462 | 236.724 | 12.049 | 42.23 | 35.529 | 1.252 |
| Overige Investeringsactiviteiten
| -33.097 | 0.343 | 0.414 | -23.61 | 0 | 13.728 | -17.539 | 0.133 | 7 | 5 | 8.39 | 0.56 | 10.5 |
| Kasstroom uit Investeringsactiviteiten
| 56.04 | 115.999 | -29.569 | -95.738 | -216.799 | 293.713 | 17.484 | -228.051 | -184.94 | -13.424 | -50.841 | -38.048 | -81.037 |
| Financieringsactiviteiten: | |||||||||||||
| Schuldaflossingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -30 | 0 | 0 | -20 | 20 |
| Uitgifte van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| -0.67 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | -0.394 | 0 | 0 | -12.015 | -60.075 | -20.025 | -50.543 | -81.352 | -60 | -0.609 | -1.17 |
| Overige Financieringsactiviteiten
| 2.885 | -12.523 | 22.828 | 31.063 | 23.901 | 13.728 | 0 | 0 | 302.138 | 30 | 0 | 0 | -0 |
| Kasstroom uit Financieringsactiviteiten
| 2.885 | -12.523 | 22.435 | 31.063 | 23.901 | -12.015 | -60.075 | -20.025 | 221.595 | -51.352 | -60 | -20.609 | 18.83 |
| Overige Informatie: | |||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | -0 | 0 |
| Netto Kasstroomverandering
| 19.665 | 89.034 | -21.938 | -71.452 | -188.855 | 313.397 | 15.467 | -143.837 | 106.84 | 5.387 | -4.383 | 32.507 | 13.691 |
| Kaspositie aan het Einde van de Periode
| 210.737 | 191.072 | 102.039 | 123.977 | 195.429 | 384.284 | 70.887 | 55.42 | 199.257 | 92.417 | 87.03 | 91.413 | 58.906 |